Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-01-07
1995-11-28
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514832, 514833, 536107, 536110, 536124, A61K 3172, C08B 3104, C08B 3502, C08L 316
Patent
active
054708419
ABSTRACT:
A metabolizable blood plasma substitute is described which contains a starch ester with a molecular weight (Mw) of>20000 Daltons and a molar substitution of 0.1 to 1.5 as a colloidal component. The starch ester is for example acetyl starch with a molecular weight (Mw) of 200000 to 230000 Daltons and a molar substitution of 0.3 to 0.5.
REFERENCES:
patent: 2362282 (1944-11-01), Lindsay
patent: 3639389 (1972-02-01), Hull
patent: 3793065 (1974-02-01), Morrison et al.
patent: 3937821 (1976-02-01), Irikura et al.
patent: 3962465 (1976-06-01), Richter et al.
patent: 3998753 (1976-12-01), Antoshkiu et al.
patent: 4061610 (1977-12-01), Glowaky et al.
patent: 4211865 (1980-07-01), Ferruti et al.
patent: 4609640 (1986-09-01), Morishita et al.
patent: 4615739 (1986-10-01), Clark et al.
patent: 4629698 (1986-12-01), Nitsch et al.
patent: 4879283 (1989-11-01), Belzer et al.
patent: 5006140 (1991-04-01), Loercks et al.
patent: 5039520 (1991-08-01), Hunter
patent: 5122539 (1992-06-01), Abraham et al.
patent: 5200398 (1993-04-01), Strasberg et al.
Asskali Fatima
Forster Harald
Nitsch Ernst
Griffin Ronald W.
Laevosan-Gesellschaft MBH
LandOfFree
Metabolizable plasma substitute does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metabolizable plasma substitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolizable plasma substitute will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2013757